-+ 0.00%
-+ 0.00%
-+ 0.00%

DKSH Partners with Grünenthal for Specialty Pain Portfolio in Asia-Pacific

MT Newswires·09/28/2026 01:28:13
Listen to the news
01:28 AM EDT, 09/28/2026 (MT Newswires) -- DKSH's (DKSH.SW) healthcare unit is collaborating with Grünenthal to support the commercialization of four products from the German drugmaker's specialty pain portfolio in the Asia-Pacific region. Under the new regional deal, the Swiss market expansion company will support the launch of Qutenza, Vimovo, Palexia and Zomig across Hong Kong, Indonesia, Malaysia, Philippines, Singapore, Taiwan, Thailand, and Vietnam, according to a Monday release. The agreement expands an existing partnership between the companies covering three medicines from Grünenthal's established portfolio.